Recent studies suggest increased cancer risk in patients with type 2 diabetes mellitus (T2DM) compared with healthy individuals. The present study aims to assess whether T2DM is associated with increased genome instability and whether a healthy diet with natural foods can improve genome stability in peripheral blood lymphocytes (PBLs). Seventy-six diabetic and 21 non-diabetic individuals were randomly assigned to either an 'intervention' or an 'information only' group. All participants received information about the beneficial effects of a healthy diet, while subjects of the intervention group received additionally 300 g of vegetables and 25 ml of plant oil rich in polyunsaturated fatty acids per day for 8 weeks. Chromosomal damage was assessed using the cytokinesis-block micronucleus (MN) cytome assay. Levels of chromosomal damage did not differ between diabetic and non-diabetic individuals. However, diabetic individuals with MN frequency above the high 50th percentile had significantly higher levels of fasting plasma glucose, glycosylated haemoglobin and were at higher risk for cardiovascular disease (CVD), assessed by the Framingham general cardiovascular risk score. Non-diabetic individuals with MN frequency above the 50th percentile had significantly lower vitamin B12 levels. The intervention with vegetables and plant oil led to significant increases in folate, γ-tocopherol, α-and β-carotene while vitamin B12 was significantly reduced. Levels of chromosomal damage were not altered, only apoptosis was slightly increased. The results suggest interactions between glycaemic control, CVD risk and genome stability in individuals with T2DM. However, a healthy diet does not improve genome damage in PBLs.
Introduction
Type 2 diabetes mellitus (T2DM) is an increasing health problem worldwide and is associated with severe complications (1) . Hyperglycaemia and insulin resistance are the main characteristics of the disease and, based on epidemiological evidence, result in increased risk for cardiovascular disease (CVD) (2, 3) and cancer (4) .
Recent meta-analysis investigating the association between T2DM and non-Hodgkin lymphoma, leukaemia, myeloma (5) , hepatocellular carcinoma (6) , pancreatic cancer (7) and colorectal cancer (8, 9) reported increased cancer risk in individuals with T2DM. However, results of epidemiological studies regarding cancer risk in T2DM patients are not consistent (10) and it is still unclear whether the association between diabetes and cancer is direct (due to hyperglycaemia) or indirect (due to shared risk factors such as obesity or smoking) (11, 12) .
A frequently used method to assess genome stability is the cytokinesis-block micronucleus cytome (CBMN) assay. The use of micronuclei (MN) frequency as a biomarker for cancer risk is based on theoretical evidence confirming the causal role of MN induction in cancer development (13) and epidemiological evidence reporting increased incidence of all cancers for subjects with high MN frequency (14) .
Shettigar et al. (15) investigated MN frequency in T2DM and healthy individuals and reported no differences between the two groups; however, MN frequency was associated with elevated glycosylated haemoglobin (HbA 1c ) (15) . Within another case control study, higher MN frequency in T2DM patients with no micro-or macrovascular complications compared with healthy individuals was found (16) . In patients with coronary artery disease, MN frequency was significantly higher in the presence of T2DM (17) . CVD is suggested to be a major determinant of MN frequency, based on correlations between MN frequency and both the prevalence (18, 19) and the severity of coronary artery disease (18) .
Growing evidence suggests that MN frequency can be modulated by dietary factors (20) (21) (22) (23) . Micronutrients play an essential role in the protection against genome damage since they are required as cofactors in DNA synthesis and repair (21) . A population study with healthy individuals suggests that at least nine micronutrients (calcium, folate, nicotinic acid, vitamin E, retinol, β-carotene, panthothenic acid, biotin and riboflavin) affect genome stability (24) . Furthermore, the beneficial effect of multiple antioxidants on MN frequency was confirmed in human intervention studies (24) (25) (26) .
Within this study, we investigated the effect of a healthy diet, realised through the supply of mainly green vegetables and the replacement of saturated fatty acids (SFA) by polyunsaturated fatty acids (PUFA) on chromosomal damage in T2DM and non-diabetic participants. The study aimed (i) to investigate differences between diabetic and non-diabetic individuals at baseline under consideration of CVD risk (27) and (ii) to assess the impact of a dietary intervention on chromosomal damage. To the best of our knowledge, this is the first dietary intervention study in T2DM patients with natural foods investigating the complete pattern of markers that are considered as relevant for carcinogenesis [MN, nuclear buds (NBuds), nucleoplasmic bridges (NPBs), cellular apoptosis and necrosis].
Materials and methods

Participants
Patients with T2DM (36 treated with insulin, 40 treated with oral antidiabetic medication) were recruited from a local diabetes clinic (Diabetes Outpatient
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Clinic, Health Centre South, Vienna, Austria). Non-diabetic individuals (n = 21) were partners of the diabetic subjects.
Individuals with T2DM had to have stable metabolic control (constant medication regarding glucose, lipid and uric acid metabolism), HbA 1c concentration <9.5%, serum total cholesterol (TC) <300 mg/dl (<7.76 mmol/l), serum triglycerides <500 mg/dl (<5.7 mmol/l) and serum creatinine <2.5 mg/dl (<221 µmol/l). Non-diabetic individuals had to be free of diabetes [based on definitions of the American Diabetes Association (ADA)] (28) and were not allowed to take any glucose lowering drugs. Otherwise the same exclusion criteria were applied.
All subjects had to have stable body weight, constant dietary habits and physical activity levels for at least 4 weeks before entry to the study. Subjects who intended to change dietary habits, frequency of physical activity or body weight within the study period were not allowed to participate. Further exclusion criteria were smoking, intake of fish oil capsules and other fatty acids. All medical therapies of subjects were continued unchanged throughout the study.
The study protocol was approved by the Ethical Committee of the City of Vienna (EK09-218-VK_NZ). The inclusion criteria were fulfilled by 151 subjects, of whom 120 gave their written consent. Out of these, 21 withdrew because of health problems unrelated to the study, digestive discomfort or scheduling conflicts. Two participants of the non-diabetic group were excluded because of elevated fasting glucose levels. The trial is registered on Current Controlled Trials (ISRCTN53451803).
Study design and dietary intervention
All participants (diabetics and non-diabetics) received information about the beneficial effects of a healthy diet with special focus on the importance of fat quality and the role of vegetables in a balanced diet. Participants were randomly assigned to the 'intervention' or 'information only' group. Subjects of the 'information only' group received only the above-mentioned information, while subjects of the 'intervention' group received additionally 300 g of vegetables and 25 ml of PUFA-rich walnut oil per day [details on sterol content and fatty acid profile see (29) ]. Participants were instructed to use the plant oil as replacement for SFA. A reference 'cup' and a booklet with recipes, instructions for replacement of SFA and usage of the plant oil (oil was not allowed to be heated up, but added to warm foods) was provided to the participants. A variety of frozen vegetables was given to the subjects every 2 weeks (list of supplied vegetables and calculated dietary composition are shown in the online supplement; supplementary Table I , available at Mutagenesis online). A dietary diary had to be completed, and fatty acid profile and various vitamin concentrations were measured to monitor compliance.
The intervention period lasted 8 weeks, followed by a period of 8 weeks in which no intervention foods were provided. Blood samples were taken before the intervention, after 4, 8 (end of intervention period) and 16 weeks. The CBMN assay was performed at baseline and after 8 weeks and therefore only data of these two time points are presented. Furthermore, participants had to complete a blood glucose profile, a dietary diary at all four blood sampling time points and a food frequency questionnaire (FFQ) at baseline and week 16.
Anthropometry, blood pressure and Framingham general cardiovascular risk
Waist circumference, body height (stadiometer: Seca, Modell 214, Hamburg, Germany) and body weight (digital scale: Seca, Bella 840, Hamburg, Germany) were measured. Body mass index (BMI) was calculated as kilogram per square metre. Furthermore, three blood pressure measurements (BpTRU Medical Devices, Coquitlam, BC, Canada) with 2-min intervals in between (the mean of the last two measurements was used) were obtained after at least 5-min rest with the subject in a seated position.
The Framingham general cardiovascular risk (27) was estimated using following variables: age, sex, tobacco use, treated/untreated systolic blood pressure, diabetes and lipid profile [TC, high-density lipoprotein (HDL) cholesterol].
Blood sampling and isolation of PBMCs
Venous blood samples were obtained after an overnight fast using heparin or serum tubes (Becton Dickinson, Schwechat, Austria). After centrifugation, serum and plasma were aliquoted, used fresh or frozen at −80°C for further analysis. Erythrocytes were washed three times with isotonic phosphate buffer, aliquoted and stored at −80°C.
Biochemical analyses
Fasting plasma glucose, HbA 1c , TC and HDL cholesterol were measured immediately by the laboratory of the Health Centre South, Vienna. HbA 1c was analysed in whole blood by high-performance liquid chromatography (HPLC) (automated Glycohemoglobin Analyzer HLC-723G8; Tosoh, Tokyo, Japan). Fasting plasma glucose was determined enzymatically by the hexokinase method (Aeroset, Abbott Diagnostics, Abbott Park, IL, USA). Serum TC and HDL cholesterol levels were measured enzymatically by an automated method (Aeroset, Abbott Laboratories, North Chicago, IL, USA) using commercial kits (Abbott).
Measurement of fatty acids, vitamins, antioxidants and homocysteine
The fatty acid profile in plasma was determined by a gas chromatograph equipped with a flame ionisation detector (30) . Identification of fatty acids was based on the samples' retention times compared with a 37 Component FAME Mix standard (Supelco, Bellefonte, USA). TotalChrom Workstation 6.3.0, Perkin Elmer was used for peak integration.
Plasma concentrations of vitamin K, α-and γ-tocopherol, retinol, lutein, α-and β-carotene were determined by reverse-phase HPLC (31) . Each vitamin was quantitated on the basis of peak area using a calibration curve generated from standard solutions.
Plasma concentrations of vitamin B12 and folic acid were measured according to routine diagnostic tests on Siemens Immulite 2000 analyzer (Siemens Healthcare Diagnostics, Tarrytown, USA) at the laboratory of the Health Centre South, Vienna using chemiluminescent enzyme immunoassay. Folic acid in erythrocytes was measured with radioimmunoassay. Standard curves were drawn and sample values calculated according to the protocol published by the kit producer (MP Biomedicals, Germany). Plasma homocysteine was measured by reversed-phase HPLC with fluorescence detector (emission wavelength: 515 nm; excitation wavelength: 385 nm) on a LiChrosphere column (5 µm, 125 × 4 mm; Merck, Hitachi, LaChrom, Austria). Potassium hydrogen phosphate buffer with 4% acetonitrile was used as mobile phase (32) .
CBMN assay
PBMCs were isolated using Cell Preparation Tubes (Becton Dickinson, Schwechat, Austria) following the manufacturer's instructions. The CBMN assay was performed according to the protocol of Fenech (33) . A concentration of 1 × 10 6 cells/ml in culture medium was stimulated to mitotic division with phytohaemagglutinin (PHA; PAA, Austria) and incubated at 37°C, 5% CO 2 . Forty-four hours after PHA stimulation, cytocalasin B (Sigma Aldrich, Austria) was added to block cytokinesis. After a total of 72 h of incubation, cells were transferred to slides using cytocentrifuge (Shandon Cytospin 3) and stained (Diff-Qick; Medion Diagnostics, Switzerland). For each subject, duplicates were performed and two slides of each duplicate were prepared. The frequency of binucleated cells (BN) with MN, NPBs and NBuds was scored in 2000 BN according to published criteria (33, 34) . Furthermore, the number of necrotic and apoptotic cells as well as the nuclear division index (NDI) (33) were determined.
To minimise the potential confounding effect of sex, MN frequency was adjusted for sex by using the ratio of mean MN frequency in males and females as correction factor as suggested by Fenech et al. (35) . Age was not included, since no correlation between MN frequency and age was observed, due to the narrow age range of the participants.
Statistical analysis
Statistical analyses were performed using SPSS 17.0 for Windows (SPSS, Chicago, IL, USA). Normal distribution within the data set was tested by histograms and the Kolmogorov-Smirnov test. Independent samples t-test (for parametric data) or Mann-Whitney U-test (for non-parametric data) was conducted to assess differences between two groups. Multiple group comparisons were performed with one-way analysis of variance (ANOVA) followed by Bonferroni post hoc test or Kruskal-Wallis H-test if the assumptions of normality or homogeneity of variance were not met.
The effect of the intervention was assessed by (i) comparing baseline values with values after 8 weeks of intervention (univariate ANOVA) and (ii) by comparing the change after 8 weeks of intervention between the two treatment groups (univariate ANOVA, with treatment and health status as fixed factors). Statistical tests were carried out on log-transformed data (e.g. log MN week 8 -log MN week 0). Pearson correlation and Spearman rank correlation were used to evaluate the association between variables. Results were considered significant at P < 0.05. The statistical power of the study was based on a minimal detectable change of 5.8 BN with MN per 1000 BN from baseline to week 8, a standard deviation of 8.1 and a significance level of 5%. A reduction by 5.8 BN with MN per 1000 BN was considered to be pathologically significant, since such a change can be induced by exposure to 10 cGy of ionizing radiation (36) . The sum of diabetic and non-diabetic participants was divided into intervention and information group, and thereby a statistical power of >90% for each subgroup was reached.
Results
Baseline data
In total, 97 individuals completed the study. There were no significant differences in clinical features, nutritional status or chromosomal damage between the intervention and information group at baseline. Only age and NDI were slightly, but significantly different between the two groups ( Table I) .
As expected, fasting plasma glucose, HbA 1c and CVD risk were significantly higher in diabetic compared with non-diabetic individuals (8.52 ± 2.20 vs. 5.63 ± 0.50 mmol/l, P < 0.001; 7.55 ± 0.89 vs. 5.79 ± 0.26%, P < 0.001; 21.67 ± 8.01 vs. 11.61 ± 6.59, P < 0.001, respectively). Furthermore, vitamin B12 was significantly lower in diabetic participants (309 ± 139 vs. 405 ± 152 pmol/l; P = 0.011). The percentage number of participants in the two treatment groups with low levels of vitamin B12, plasma and red blood cell folate are shown in Table II .
Correlation analysis identified relationships between fasting plasma glucose and MN frequency (r = 0.283, P = 0.006, adjusted for sex). Also self-measured fasting glucose levels were correlated to MN frequency (r = 0.359, P = 0.007, adjusted for sex). Regarding age, plasma and erythrocyte nutrient status, there were no correlations with any CBMN assay parameter.
Comparisons of baseline data between male and female volunteers showed a 44% greater MN frequency in females relative to males (25.0 ± 8.4 vs. 17.4 ± 5.1; P < 0.001), a 21% greater number of necrotic cells (1.54 ± 0.79 vs. 1.21 ± 0.69%; P = 0.037) and 12% higher homocysteine levels (13.4 ± 2.74 vs. 11.8 ± 2.93 µmol/l; P = 0.010) in males compared with females.
To assess the influence of CVD risk, glucose and nutrient status on MN frequency, participants were stratified on the basis of MN frequency at baseline using the 50th percentile. The results (Figure 1) showed that diabetic subjects with high MN frequency have significantly higher fasting plasma glucose (P = 0.004), HbA 1c (P = 0.048) and CVD risk (P = 0.021). Nondiabetic participants with high MN frequency had significantly lower plasma vitamin B12 levels (P = 0.005) compared with non-diabetic individuals with low MN frequency.
Intervention study
The measurements of fatty acid profile, tocopherols, carotenoids, folic acid and vitamin K confirmed good dietary compliance: plasma levels of linoleic (+13%; P < 0.001) and linolenic acid (+60%; P < 0.001), γ-tocopherol (+37%; P < 0.001), lutein (+58%; P < 0.001), α-carotene (+92%; P < 0.001), β-carotene (+53%; P < 0.001) and vitamin K (+154%; P < 0.001) were significantly increased after 8 weeks of intervention with vegetables and oil compared with baseline [for details see (29) ]. Also plasma folate (+13%; P = 0.003) and red blood cell folate (+10%; P = 0.043) were significantly increased (Table III) . None of the compounds changed significantly in the information group, apart from β-carotene showing a significant increase after 8 weeks (+31%; P = 0.007). However, the changes in all the compliance markers were significantly higher in the intervention group compared with the information group. Vitamin B12 was significantly reduced (−9%; P = 0.003) in subjects of the intervention group, but changes were not significantly different between the two treatment groups. No effects on homocysteine levels in any of the groups were observed (Table III) .
The changes in folate and vitamin B12 levels led to changes in the percentage number of deficient participants (Table II) . HbA 1c was improved in diabetic individuals in both, the intervention (baseline: 7.58 ± 0.93%, week 8: 7.36 ± 0.80) and information group (baseline: 7.48 ± 0.80%, week 8: 7.25 ± 0.89%), while no changes were observed in non-diabetic individuals.
The results of the CBMN assay are shown in Table IV . No changes in MN, NBud or NPB frequency in the information or intervention group were observed. There was a significant treatment × health interaction (P = 0.015) with respect to the changes in NBuds. The intervention with vegetables and plant oil led to a significant increase in apoptosis. There was no effect on necrosis and NDI.
Discussion
The number of people suffering from diabetes is increasing (1) as well as the evidence for a positive association between T2DM and both, cancer (4) and CVD risk (37, 38) . Life style and especially diet is suggested to affect the onset and progression of the above-mentioned diseases (39, 40) . Therefore, we designed this human intervention study (i) to assess genome stability, measured by the CBMN assay, in diabetic and nondiabetic individuals and (ii) to evaluate the impact of a healthy diet rich in vegetables and PUFA-rich plant oil as a replacement of SFA on chromosomal damage.
Within this trial, levels of chromosomal damage were not significantly different between diabetic and non-diabetic In the article, ITDM2 and NIDDM are referred to as 'diabetics' (information group: 22 diabetic subjects, intervention group: 54 diabetic subjects). individuals. This finding is in contrast to a case control study reporting higher MN frequency in diabetic individuals (16) . However, it is worth mentioning that diabetic patients of the Mexican cohort had rather high HbA 1c (9.44 ± 1.88%) and fasting plasma glucose levels (209.72 ± 78.11 mg/dl, equal to 11.64 ± 4.34 mmol/l), indicating poor glycaemic control, compared with the well-controlled diabetic patients of this trial. The significant correlation between MN frequency and fasting plasma glucose levels suggests increased chromosomal damage, manifested as increased MN frequency, with worsening of glycaemic control. The importance of proper blood glucose control could also be confirmed by the significantly lower levels of fasting plasma glucose and HbA 1c levels in diabetic subjects in the low 50th percentile of MN frequency relative to those in the high 50th percentile.
There is growing evidence that DNA damage is also present in CVD (18, 41) and that MN frequency is associated prospectively with increased cardiovascular disease mortality (42) . Furthermore, Andreassi et al. (17) suggested diabetes beside chronic nitrate treatment as a major independent determinant of increased MN frequency in patients with coronary artery disease. Within this trial, we found increased CVD risk (assessed by the Framingham general cardiovascular risk score) in diabetic individuals with high MN frequency compared with those with low MN frequency.
Another important modulating factor regarding chromosomal stability is micronutrient intake. Folate plays a key role within the DNA methylation and DNA biosynthesis pathways (43) . In case of folate as well as vitamin B12 deficiency, uracil is incorporated into DNA. Excessive uracil incorporation leads Data are presented as means ± SD.
a P values refer to differences between baseline and week 8 in the information and intervention group and were calculated with univariate ANOVA.
to point mutations resulting in DNA strand breaks, chromosome breakage and MN formation (44) . Also antioxidants are needed for the inactivation of free radicals to prevent interactions with the DNA backbone, leading to DNA strand breaks and MN formation [for review see (22, 23) ]. Within this trial, plasma and erythrocyte folate concentrations were significantly increased after 8 weeks of vegetable and oil intervention. However, biomarkers for chromosomal damage remained unchanged, only apoptosis was significantly increased. Levels of vitamin B12 were reduced after the intervention, probably due to a replacement of meat and meat products by vegetables. A decreased consumption of animal products was also confirmed by FFQ, which were collected at baseline and week 16 (8 weeks after end of intervention; data not shown).
Based on an intervention study with folate and vitamin B12, Fenech et al. (35, 44) suggest red blood cell folate concentrations >700 nmol/l, plasma vitamin B12 >300 pmol/l and homocysteine levels <7.5 µmol/l to minimise MN formation. Even though folic acid was increased, only 6% of participants assigned to the intervention group had red blood cell folate levels >700 nmol/l. The required homocysteine and B12 levels were reached by 2% and 26% of subjects of the intervention group, respectively. The vitamin B12 threshold of 300 pmol/l to minimise MN formation could be confirmed within this study, since non-diabetic individuals in the high 50th percentile of MN frequency had significantly lower vitamin B12 plasma levels (320 ± 130 vs. 512 ± 121 pmol/l).
Based on an Australian dietary intake survey (24) , apart from folate, calcium, nicotinic acid, vitamin E, retinol (reduction in MN frequency in the tertile with high intake), pantothenic acid, biotin and riboflavin (increase in MN frequency in the tertile with high intake) also were identified as having strong impact on genome health. For β-carotene, a U-shaped dose-response for dietary intake with high MN frequency in the high and low tertile was observed.
Human intervention trials with single antioxidants such as vitamin C (2 g) (45) or vitamin E (50 mg as cereals followed by 335 mg as of soy bean oil, each for 8 weeks) observed either no effect on MN frequency or the obtained results were not conclusive since MN frequency was reduced in both, the control and intervention group (46) . The authors concluded that vitamin E is unlikely to affect chromosomal damage due to its activity only in lipid phases and the probably low increase of vitamin E in nuclear membranes, which are surrounding the DNA. Intervention studies with multiple antioxidants supplementing 1000 mg ascorbic acid and 335.5 mg vitamin E (47), a mixed supplement consisting of 100 mg α-tocopherol, 6 mg β-carotene, 100 mg vitamin C and 50 µg selenium (26), or a vitamin-antioxidant mixture containing 3 mg vitamin A, 30 mg α-tocopherol, 150 mg ascorbic acid, 15 mg β-carotene, 0.2 mg folic acid and 75 mg rutin (25) reported positive effects on MN frequency.
In this trial, no supplements were administered. Antioxidant and vitamin concentrations were increased by providing natural foods. Therefore, we hypothesise that a reason for not observing any change in genome damage could be the 'lower administered dose' of vitamins and antioxidants compared with the above-mentioned trials. Only apoptosis was significantly increased during the intervention. However, considering the percentage of apoptotic cells, this increase might not be of biological significance. The results obtained within this trial were in the normal range (33) and comparable to other recent studies of the Austrian population (48, 49) .
There are, however, two limitations in the present study. First, an intervention period of 8 weeks is at the lower end to detect changes in levels of genome damage in PBMCs, since their half-life is longer (50) . Second, due to the modest number of healthy participants, effects of the intervention were evaluated together, in diabetic and non-diabetic individuals. Anyhow, the number of participants in the information and intervention group was big enough to detect changes of biological significance.
In conclusion, T2DM patients with well-controlled glucose metabolism do not have higher rates of genome damage compared with healthy individuals. However, glycaemic control, CVD risk and vitamin B12 could be identified as important factors being associated with MN frequency. The intervention with 300 g vegetables and 25 ml PUFA-rich plant oil was found to have no impact on levels of MN, NBud and NPB frequency. Based on the measured concentrations of vitamins and antioxidants, we conclude that it is unlikely to reach concentrations shown to protect from genome damage via a daily consumption of 300 g vegetables and 25 ml plant oil for 8 weeks.
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